Description
While sleep disruption and thalamic connectivity alterations were identified as relevant factors, the mechanistic links and directional causality between these phenomena and cognitive decline remain unclear. Understanding these relationships could reveal new therapeutic windows for intervention.
Source: Debate session sess_SDA-2026-04-04-frontier-connectomics-84acb35a (Analysis: SDA-2026-04-04-frontier-connectomics-84acb35a)
Resolution criteria
Resolved when longitudinal human sleep, thalamic connectivity, amyloid/tau biomarker, and cognition data establish directionality among sleep-wake disruption, thalamic network change, and AD progression. Required evidence: at least two time points with actigraphy or polysomnography, resting-state or diffusion MRI thalamic connectivity metrics, amyloid/tau PET or CSF/plasma biomarkers, and causal mediation or cross-lagged modeling. Interventional sleep or thalamic neuromodulation data showing downstream biomarker/cognitive change would also close the gap.
Evidence summary
Resolved by hypothesis h-9e9fee95: Circadian Glymphatic Entrainment via Targeted Orexin Receptor Modulation. Score: 0.860. Supporting PMIDs: 24136970, 30513028, 31852950, 34686377, 28877966.